3,4-dihydro-2H-pyran → 4-(Benzyloxy)-7-{(1R)-2-bromo-1-[tetrahydro-2H-pyran-2-yloxy]ethyl}-1,3-benzothiazol-2(3H)-one
반응식
[CH2:1]([O:8][C:9]1[C:14]2[NH:15][C:16](=[O:18])[S:17][C:13]=2[C:12]([C@@H:19]([OH:22])[CH2:20][Br:21])=[CH:11][CH:10]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C1(C)C=CC(S([O-])(=O)=O)=CC=1.[NH+]1C=CC=CC=1.[O:40]1[CH:45]=[CH:44][CH2:43][CH2:42][CH2:41]1>C(Cl)Cl>[CH2:1]([O:8][C:9]1[C:14]2[NH:15][C:16](=[O:18])[S:17][C:13]=2[C:12]([C@@H:19]([O:22][CH:41]2[CH2:42][CH2:43][CH2:44][CH2:45][O:40]2)[CH2:20][Br:21])=[CH:11][CH:10]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1참가 물질
5
반응물 3
생성물 1
시약·촉매·용매 1
실험 절차
To a stirred solution of 4-(benzyloxy)-7-[(1R)-2-bromo-1-hydroxyethyl]-1,3-benzothiazol-2(3H)-one (31 mg) in dry DCM (5 ml) under nitrogen, was added pyridinium p-toluenesulphonate (5 mg), followed by 3,4-dihydro-2H-pyran (30 μl). The mixture was evaporated in vacuo after 18 h and purified on a 2 g silica SPE cartridge, eluting with a stepped gradient 10% to 100% DCM-cyclohexane mixtures, to give the title compound (42 mg). LCMS RT=3.72 and 3.78 min.
후처리
- customThe mixture was evaporated in vacuo after 18 h
- custompurified on a 2 g silica SPE cartridge
- washeluting with a stepped gradient 10% to 100% DCM-cyclohexane mixtures
출처 및 근거
- ORD 기록
- ord-b3f72a61eb944a70a5d9da7854141211
- 출처 데이터셋
- uspto-grants-2008_07
- 특허 번호
- US07402598B2
반응 노트
불러오는 중…